Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)

(Unaudited)

July 3,
2021

January 2,
2021

Assets

Current assets:

   Cash and cash equivalents

$   303,084

$   202,720

   Short-term investments

314,183

521,963

   Accounts receivable, net

99,546

95,169

   Inventories

52,269

47,861

   Prepaid expenses and other current assets

94,378

87,103

   Current assets held for sale

297,543

21,005

Total current assets

1,161,003

975,821

Property and equipment, net

139,362

135,803

Goodwill

376,389

376,389

Other intangible assets, net

140,581

163,483

Other assets, net

78,667

76,675

Non-current assets held for sale

--

265,316

Total assets

$1,896,002

$1,993,487

Liabilities and Stockholders' Equity

Current liabilities:

   Accounts payable

$     70,820

$     54,949

   Current portion of convertible debt, net

--

134,480

   Deferred revenue and returns liability

12,811

12,986

   Other current liabilities

70,552

81,650

   Current liabilities held for sale

699

433

Total current liabilities

154,882

284,498

Convertible debt, net

439,654

428,945

Other non-current liabilities

73,712

79,752

Non-current liabilities held for sale

--

451

Total liabilities

668,248

793,646

Commitments and contingencies

Stockholders' equity:

   Preferred stock – $0.0001 par value; 10,000 shares authorized; no

      shares issued

--

--

   Common stock – $0.0001 par value; 250,000 shares authorized;  

      44,764 and 43,925 shares issued and outstanding at

      July 3, 2021 and January 2, 2021, respectively

4

4

   Additional paid-in capital

200,716

204,359

   Retained earnings

1,027,105

993,664

   Accumulated other comprehensive income (loss)

(71)

1,814

Total stockholders' equity

1,227,754

1,199,841

Total liabilities and stockholders' equity

$1,896,002

$1,993,487